InvestorsHub Logo

sunspotter

05/14/15 9:51 AM

#2763 RE: DITRstocks #2757

Not sure I agree.

The results of the study, even if it was designed for safety purposes, were equivocal at best when looking at clinical outcomes.

As soon as I saw the PR, I knew what Mr. Market would say.